187 related articles for article (PubMed ID: 30336979)
21. Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression.
Li JM; Jiang GM; Zhao L; Yang F; Yuan WQ; Wang H; Luo YQ
Oncol Rep; 2019 Nov; 42(5):1725-1734. PubMed ID: 31436301
[TBL] [Abstract][Full Text] [Related]
22. Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.
Vincenzi B; Zoccoli A; Schiavon G; Iuliani M; Pantano F; Dell'aquila E; Ratta R; Muda AO; Perrone G; Brunelli C; Correale P; Riva E; Russo A; Loupakis F; Falcone A; Santini D; Tonini G
Eur J Cancer; 2013 Apr; 49(6):1501-8. PubMed ID: 23266047
[TBL] [Abstract][Full Text] [Related]
23. Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression.
Huang WS; Lin CT; Chen CN; Chang SF; Chang HI; Lee KC
J Cell Biochem; 2018 Aug; 119(8):6943-6952. PubMed ID: 29737584
[TBL] [Abstract][Full Text] [Related]
24. DUSP11 - An RNA phosphatase that regulates host and viral non-coding RNAs in mammalian cells.
Burke JM; Sullivan CS
RNA Biol; 2017 Nov; 14(11):1457-1465. PubMed ID: 28296624
[TBL] [Abstract][Full Text] [Related]
25. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
[TBL] [Abstract][Full Text] [Related]
26. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
28. Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.
Pouliot LM; Shen DW; Suzuki T; Hall MD; Gottesman MM
Exp Cell Res; 2013 Feb; 319(4):566-74. PubMed ID: 23137650
[TBL] [Abstract][Full Text] [Related]
29. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
Zhang J; Li C; Sun L; Sun D; Zhao T
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
[TBL] [Abstract][Full Text] [Related]
30. Valproic acid causes proteasomal degradation of DICER and influences miRNA expression.
Zhang Z; Convertini P; Shen M; Xu X; Lemoine F; de la Grange P; Andres DA; Stamm S
PLoS One; 2013; 8(12):e82895. PubMed ID: 24358235
[TBL] [Abstract][Full Text] [Related]
31. Sequence- and structure-based analysis of proteins involved in miRNA biogenesis.
Sharma C; Mohanty D
J Biomol Struct Dyn; 2018 Jan; 36(1):139-151. PubMed ID: 27928938
[TBL] [Abstract][Full Text] [Related]
32. Drosha, Dicer-1 and Argonaute-1 in the desert locust: phylogenetic analyses, transcript profiling and regulation during phase transition and feeding.
Wynant N; Santos D; Subramanyam SH; Verlinden H; Vanden Broeck J
J Insect Physiol; 2015 Apr; 75():20-9. PubMed ID: 25746231
[TBL] [Abstract][Full Text] [Related]
33. microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
Tao J; Wu D; Li P; Xu B; Lu Q; Zhang W
Mol Med Rep; 2012 Jan; 5(1):167-72. PubMed ID: 21935572
[TBL] [Abstract][Full Text] [Related]
34. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.
Casey Klockow L; Sharifi HJ; Wen X; Flagg M; Furuya AK; Nekorchuk M; de Noronha CM
Virology; 2013 Sep; 444(1-2):191-202. PubMed ID: 23849790
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-185 oscillation controls circadian amplitude of mouse Cryptochrome 1 via translational regulation.
Lee KH; Kim SH; Lee HR; Kim W; Kim DY; Shin JC; Yoo SH; Kim KT
Mol Biol Cell; 2013 Jul; 24(14):2248-55. PubMed ID: 23699394
[TBL] [Abstract][Full Text] [Related]
36. The RNA-RNA base pairing potential of human Dicer and Ago2 proteins.
Pokornowska M; Milewski MC; Ciechanowska K; Szczepańska A; Wojnicka M; Radogostowicz Z; Figlerowicz M; Kurzynska-Kokorniak A
Cell Mol Life Sci; 2020 Aug; 77(16):3231-3244. PubMed ID: 31655860
[TBL] [Abstract][Full Text] [Related]
37. The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities.
Kurzynska-Kokorniak A; Koralewska N; Pokornowska M; Urbanowicz A; Tworak A; Mickiewicz A; Figlerowicz M
Nucleic Acids Res; 2015 May; 43(9):4365-80. PubMed ID: 25883138
[TBL] [Abstract][Full Text] [Related]
38. [The effect of silencing Dicer by small interference RNA on the biological characteristics of human glioma cells].
Zhang AL; Kang CS; Han L; Wang GX; Jia ZF; Pu PY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):521-4. PubMed ID: 19806572
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.
Jakymiw A; Patel RS; Deming N; Bhattacharyya I; Shah P; Lamont RJ; Stewart CM; Cohen DM; Chan EK
Genes Chromosomes Cancer; 2010 Jun; 49(6):549-59. PubMed ID: 20232482
[TBL] [Abstract][Full Text] [Related]
40.
Hisamatsu T; McGuire M; Wu SY; Rupaimoole R; Pradeep S; Bayraktar E; Noh K; Hu W; Hansen JM; Lyons Y; Gharpure KM; Nagaraja AS; Mangala LS; Mitamura T; Rodriguez-Aguayo C; Eun YG; Rose J; Bartholomeusz G; Ivan C; Lee JS; Matsuo K; Frumovitz M; Wong KK; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2019 Jan; 18(1):162-172. PubMed ID: 30305341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
